Neuralstem’s HK532-IGF-1 neural stem cells therapy for Alzheimer’s disease … – News-Medical.net
Smarter Analyst |
Neuralstem's HK532-IGF-1 neural stem cells therapy for Alzheimer's disease …
News-Medical.net Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells … Preclinical Data On Neuralstem's Genetically Modified HK532-IGF-1 Stem Cells … Neuralstem (CUR) Announces Presentation of Encouraging HK532-IGF-1 … Morning Buzz: Neuralstem (CUR), Celladon Corporation (CLDN), Real Goods … |
